- cafead   Aug 08, 2023 at 10:32: AM
via FibroGen endured clinical setbacks and a leadership shake-up in recent months, but the California biotech remains optimistic about its path forward, the company said Monday during its second-quarter 2023 earnings report.
article source
article source